Featured
article
- Get link
- X
- Other Apps
RFK Jr. Poised to Announce Controversial Link Between Tylenol Use in Pregnancy and Autism
U.S. Health Secretary Robert F. Kennedy Jr. is preparing to release a Department of Health and Human Services report that will allege a potential connection between the use of Tylenol (acetaminophen) during pregnancy and autism. The forthcoming report, expected later this month, will also propose that folinic acid — a form of folate — could help alleviate symptoms of autism in some individuals.
Tylenol, manufactured by Kenvue, is one of the most widely used over-the-counter pain relievers, including among pregnant women. While Kennedy’s report is anticipated to highlight low folate levels and acetaminophen exposure as possible contributors to autism, there is currently no established scientific consensus supporting a causal link.
Kenvue has strongly rejected the claim, stating that decades of research and regulatory guidance affirm the drug’s safety when used as directed. The U.S. Food and Drug Administration and leading medical organizations maintain that acetaminophen remains a safe option for pain relief during pregnancy, provided it is taken under medical advice.
The announcement is expected to reignite debate over the causes of autism, a condition affecting roughly one in 31 U.S. children, and could have significant implications for public health guidance and ongoing legal battles over the drug’s safety.
Popular Posts
Weekly Market Snapshot: TSX Holds Near Records, Wall Street Wobbles on Hot Jobs Report, BoC Opens Door to Hikes (Aug 31–Sept 4)
- Get link
- X
- Other Apps
Global Markets Weekly Wrap: TSX Hits 35,274 as Wall Street and Europe Rally
- Get link
- X
- Other Apps
Comments
Post a Comment